BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9310956)

  • 1. Apoptosis in human pituitary adenomas: a morphologic and in situ end-labeling study.
    Kontogeorgos G; Sambaziotis D; Piaditis G; Karameris A
    Mod Pathol; 1997 Sep; 10(9):921-6. PubMed ID: 9310956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary corticotroph adenoma containing many apoptotic cells: a histologic, immunohistochemical, ultrastructural and molecular study.
    Messini I; Kontogeorgos G; Kovacs K; Horvath E; Smyth HS
    Ultrastruct Pathol; 2002; 26(1):27-32. PubMed ID: 12028656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A light and electron microscopical study of pituitary adenomas.
    Stefăneanu L; Taşcă C; Coculescu M
    Endocrinologie; 1981; 19(4):243-8. PubMed ID: 7323648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary adenomas. Correlation of the cytologic appearance with biologic behavior.
    Pegolo G; Buckwalter JG; Weiss MH; Hinton DR
    Acta Cytol; 1995; 39(5):887-92. PubMed ID: 7571965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinico-pathologic study of pituitary adenomas.
    Sarkar C; Roy S; Kochupillai N; Gupta N; Tandon PN
    Indian J Med Res; 1990 Oct; 92():315-23. PubMed ID: 2272669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal differentiation and expression of neural epitopes in pituitary adenomas.
    Johnson MD; Fan X; Bourne P; Walters D
    J Histochem Cytochem; 2007 Dec; 55(12):1265-71. PubMed ID: 17875653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
    Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW
    Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic and immunohistochemical characterization of spontaneous pituitary adenomas in fourteen cynomolgus macaques (Macaca fascicularis).
    Remick AK; Wood CE; Cann JA; Gee MK; Feiste EA; Kock ND; Cline JM
    Vet Pathol; 2006 Jul; 43(4):484-93. PubMed ID: 16846990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive markers of pituitary adenoma behavior.
    Kontogeorgos G
    Neuroendocrinology; 2006; 83(3-4):179-88. PubMed ID: 17047381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of pituitary adenomas on touch preparations assisted by immunocytochemistry.
    Kontogeorgos G; Bassiouka I; Giannou P; Vamvassakis E; Rologis D; Orphanidis G
    Acta Cytol; 1995; 39(2):141-52. PubMed ID: 7887060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indices of apoptosis and proliferation as potential prognostic markers in non-functioning pituitary adenomas.
    Ibrahim AE; Pickering RM; Gawne-Cain ML; King S; Lees PD; Ellison DW
    Clin Neuropathol; 2004; 23(1):8-15. PubMed ID: 14986928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically non-functioning human pituitary adenomas.
    Asa SL; Kovacs K
    Can J Neurol Sci; 1992 May; 19(2):228-35. PubMed ID: 1623451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of ghrelin in somatotroph and other types of pituitary adenomas.
    Wasko R; Jaskula M; Kotwicka M; Andrusiewicz M; Jankowska A; Liebert W; Sowinski J
    Neuro Endocrinol Lett; 2008 Dec; 29(6):929-38. PubMed ID: 19112387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of neuro D1 in human normal pituitaries and pituitary adenomas.
    Oyama K; Sanno N; Teramoto A; Osamura RY
    Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of neurotensin and its receptors in pituitary adenomas.
    Giorgi RR; Chile T; Bello AR; Reyes R; Fortes MA; Machado MC; Cescato VA; Musolino NR; Bronstein MD; Giannella-Neto D; Corrêa-Giannella ML
    J Neuroendocrinol; 2008 Sep; 20(9):1052-7. PubMed ID: 18624930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic correlations of silent corticotroph adenomas of the pituitary: report of four cases and literature review.
    Sahli R; Christ ER; Seiler R; Kappeler A; Vajtai I
    Pathol Res Pract; 2006; 202(6):457-64. PubMed ID: 16497445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas.
    Niveiro M; Aranda FI; Peiró G; Alenda C; Picó A
    Hum Pathol; 2005 Oct; 36(10):1090-5. PubMed ID: 16226108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDKN2A/p16 inactivation is related to pituitary adenoma type and size.
    Seemann N; Kuhn D; Wrocklage C; Keyvani K; Hackl W; Buchfelder M; Fahlbusch R; Paulus W
    J Pathol; 2001 Apr; 193(4):491-7. PubMed ID: 11276008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral vectors efficiently transduce human gonadotroph and somatotroph adenomas in vitro. Targeted expression of transgene by pituitary hormone promoters.
    Roche C; Zamora AJ; Taïeb D; Lavaque E; Rasolonjanahary R; Dufour H; Bagnis C; Enjalbert A; Barlier A
    J Endocrinol; 2004 Oct; 183(1):217-33. PubMed ID: 15525589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.